Since its founding in 1987, Gilead has been working toward a healthier world for all people and finding solutions to unmet medical needs. In the spirit of this vision, Gilead invests in developing medical breakthroughs that were previously considered impossible. Gilead has developed more than 25 medications aimed at improving treatment for some of the most difficult conditions to treat and, in some cases, even achieving a cure. Through this, Gilead has successfully reached millions of people around the world.
In our fight against the world's most dangerous diseases, we set ambitious goals – and achieve them. The vision before us is to create a healthier world for everyone, which means developing innovative treatments that give patients new hope, broadly expanding access to our treatments for people facing or at risk of life-threatening diseases, and combating health inequalities and barriers that prevent access to medical services.
Thanks to our ambition, we have succeeded in finding a cure for hepatitis and supporting a revolution in the treatment and prevention of AIDS. Our activities over the past 35 years, which included groundbreaking access programs, have helped and continue to help improve the health of millions of people around the world. Our innovative developments provide assistance to people suffering from a variety of diseases and health issues including cancer, viral hepatitis, HIV, and COVID-19. Our 15,000 employees worldwide know that working at Gilead means the real ability to impact patients' lives.
Today, we continue working to find cures for additional viral diseases and certain types of cancer. We stand at the forefront of the effort to eradicate the AIDS epidemic worldwide and work determinedly to achieve this goal. Our aspiration is to provide patients with all the best products of scientific innovation, whether innovative antiviral treatments, revolutionary approaches to cancer treatment, or new medications for inflammatory diseases. We continue to expand our areas of activity to help as many patients as possible.
We achieve these goals through investment in groundbreaking scientific research, collaboration with organizations that share our vision, and expanding access while neutralizing social barriers to receiving medical treatment. Expanding our activities also means a broader view of our responsibility toward society, the communities we aspire to serve, and the environment in which we work. At the heart of our activities are our teams and the organizational culture we build, where different opinions and beliefs are welcomed and where every person can develop personally and professionally, and together, we all contribute to creating change for the patients and communities we serve.
We know that the goals we set today can become tomorrow's breakthroughs. At Gilead, we remain faithful to our goals with commitment and courage, united in our vision to improve patients' quality of life and create a healthier world for future generations.
Gilead Israel was established in January 2016 with the goal of improving the quality of life for patients in Israel. From the outset, we believed that the only way to achieve these goals is to become the partner of choice for any organization or individual in the healthcare world who identifies with our vision. We collaborate with the Ministry of Health, HMOs, hospitals, medical teams, and patient organizations – all for the benefit of patients and their families. We believe that collaboration is the key to realizing the vision of a healthier society and maximizing support for patients. This goal will continue to guide us and be expressed in the daily work of Gilead Israel's team members, in our investment in collaborations, in disease awareness programs, in making medications accessible, and in empowering patients.
Together with our patients and partners, we will continue to make the impossible in Israel possible.
As a physician and executive in global pharmaceutical companies, I have learned that the true value of science is realized only when it reaches the people who need it. Indeed, at Gilead we believe that medical innovation fulfills its purpose when it is made accessible to those who need it and positively impacts their lives.
Gilead has set itself the goal of promoting a better health reality for the entire population, while seeking innovative solutions to medical challenges that have not yet been addressed. Gilead has developed over 25 medications and breakthrough technologies that have provided solutions to complex medical conditions, sometimes even leading to complete recovery.
True medical innovation does not widen gaps but rather narrows them – and this requires collaboration among all relevant parties and a genuine passion for promoting health equity. At Gilead, we are committed to advancing this value and work in collaboration with the Ministry of Health, health funds, patient organizations and medical associations, as well as with diverse communities throughout Israel, in order to reduce health disparities in Israel.
Gilead's partnership over the years with the Haverim L'Refuah association is significant and advances this value, and symbolizes exactly where Gilead Israel stands and will continue to stand: a partner to anyone seeking to advance the welfare of patients in Israel and their families and to make accessible the treatment they need.
For me, this is the connection between medical knowledge and the human heart — and this is where Gilead chooses to stand.
Claudiu Cheles
CEO, Gilead Israel
